Theravance Biopharma (TBPH)

Earnings in 2025 (TTM): $47.24 Million USD

According to Theravance Biopharma 's latest financial reports the company's current earnings are $80.32 Million USD. In 2024 the company made an earning of -$44.62 Million USD, an increase over its 2023 earnings that were of -$49.27 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Theravance Biopharma from 2013 to 2025

Annual earnings

Year	Earnings	Change
2025 (TTM)	$47.24 M	-205.89%
2024	-$44.62 Million	-9.45%
2023	-$49.27 Million	-46.92%
2022	-$92.82 Million	-57.85%
2021	-$0.23 Billion	-23.16%
2020	-$0.29 Billion	18.56%
2019	-$0.25 Billion	6.9%
2018	-$0.23 Billion	-16.79%
2017	-$0.28 Billion	50.48%
2016	-$0.19 Billion	-0.39%
2015	-$0.19 Billion	-21.42%
2014	-$0.24 Billion	47.6%
2013	-$0.16 Billion

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Collegium Pharmaceutical COLL	$0.16 B	252.51%	🇺🇸 USA
Corcept Therapeutics CORT	$65.57 M	38.81%	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	$0.28 B	504.99%	🇺🇸 USA
Catalent CTLT	-$91 Million	-292.63%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Theravance Biopharma (TBPH)

Earnings in 2025 (TTM): $47.24 Million USD